Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Chloroplast genome sequencing of Stemona tuberosa

PROVIDER: PRJNA683125 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13212613_1.fastq.gz	Fastqsanger.gz
	SRR13212613_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Project description:Genome sequencing of Stemona tuberosa

| PRJNA985082 | ENA

Stemona tuberosa

Project description:Stemona tuberosa overview

| PRJNA1165386 | ENA

Project description:Transcriptome sequencing of Stemona tuberosa

| PRJNA985114 | ENA

Project description:WGS of Stemona tuberosa

| PRJNA861697 | ENA

Stemona tuberosa

Project description:Stemona tuberosa Raw sequence reads

| PRJNA1164997 | ENA

Project description:The complete chloroplast genome of Stemona sessilifolia (Miq.) Miq.

| PRJNA718648 | ENA

Stemona

Project description:Stemona Genome sequencing and assembly

| PRJNA449184 | ENA

Dual Roles for CND1 in Maintenances of Nuclear and Chloroplast Genome Stability in Plants [ChIP-seq]

Project description:The coordination of chloroplast and nuclear genome status are critical for plant cell function, but the mechanism remain largely unclear. In this study, we report that Arabidopsis thaliana CHLOROPLAST AND NUCLEUS DUAL-LOCALIZED PROTEIN 1 (CND1) maintains genome stability in both the chloroplast and the nucleus.

2022-12-13 | GSE220489 | GEO

Stemona sessilifolia

Project description:Stemona sessilifolia Genome sequencing and assembly

| PRJNA1073764 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data